Top

Published in:

01-03-2008 | Original Article

Opioid use determines success of videothoracoscopic splanchnicectomy in chronic pancreatic pain patients

Authors: Tomasz Stefaniak, Ad Vingerhoets, Wojciech Makarewicz, Lukasz Kaska, Jarek Kobiela, Barbara Kwiecińska, Aleksander Stanek, Andrzej J. Lachinski, Zbigniew Śledziński

Published in: Langenbeck's Archives of Surgery | Issue 2/2008

Abstract

Objective

Videoscopic splanchnicectomy (VSPL) is a method of pain relief in chronic pancreatitis patients. Because this method is not equally effective in all patients, this study was designed to identify the factors determining the unfavorable results of VSPL.

Materials and methods

This is a non-randomized prospective case-controlled study designed to compare a group of patients suffering from chronic pancreatitis treated with VSPL (N = 48) versus a group of patients treated symptomatically (N = 42). The outcome was measured as the intensity of pain ailments [visual analog scale (VAS)-pain scale] and subjective satisfaction of the patients from the surgical treatment [Functional Assessment of Chronic Illness Therapy-Treatment Satisfaction (FACIT-TS)]. The predictive variables considered in this study were: age, sex, emotional status, social support (the two last variables were measured by subscales of quality-of-life questionnaire from the group of FACIT), history of previous surgical treatment, and opioid use for at least 3 months before VSPL. The follow-up was 18 months. Logistic regression was performed using dichotomized pain as outcome variable: high score more than 66.7 on VAS scale and low under 50 points on VAS scale 18 months after VSPL.

Results

VSPL significantly reduced the pain ailments at all points of the study when compared to the control. However, the pain intensity at the end of the study was higher than directly after the surgery. In the patients treated with opioids before the surgery, the pain intensity was significantly higher than in the patients not using this group of drugs. Logistic regression revealed that opioid administration before VSPL was the most important predictor of high pain scores 18 months after the surgery.

Conclusion

When planning the VSPL in the treatment of pain in patients suffering from chronic pancreatitis, it is necessary to take into consideration the previous chronic use of opioids, as this variable can significantly influence poorer results of this surgical pain management.

Saenz A, Kuriansky J, Salvador L, Astudillo E, Cardona V, Shabtai M, Fernandez-Cruz L (2000) Thoracoscopic splanchnicectomy for pain control in patients with unresectable carcinoma of the pancreas. Surg Endosc 14(8):717–720PubMedCrossRef

Stefaniak T, Basinski A, Vingerhoets A, Makarewicz W, Connor S, Kaska L, Stanek A, Kwiecinska B, Lachinski AJ, Sledzinski Z (2005) A comparison of two invasive techniques in the management of intractable pain due to inoperable pancreatic cancer: neurolytic celiac plexus block and videothoracoscopic splanchnicectomy. Eur J Surg Oncol 31(7):768–773PubMedCrossRef

Bradley EL 3rd, Bem J (2003) Nerve blocks and neuroablative surgery for chronic pancreatitis. World J Surg 27(11):1241–1248PubMedCrossRef

Ihse I, Zoucas E, Gyllstedt E, Lillo-Gil R, Andren-Sandberg A (1999) Bilateral thoracoscopic splanchnicectomy: effects on pancreatic pain and function. Ann Surg 230(6):785–790PubMedCrossRef

Makarewicz W, Stefaniak T, Kossakowska M, Basinski A, Suchorzewski M, Stanek A, Gruca ZB (2003) Quality of life improvement after videothoracoscopic splanchnicectomy in chronic pancreatitis patients: case control study. World J Surg 27(8):906–911PubMedCrossRef

Maher JW, Johlin FC, Heitshusen D (2001) Long-term follow-up of thoracoscopic splanchnicectomy for chronic pancreatitis pain. Surg Endosc 15:706–709PubMedCrossRef

Makarewicz W, Stefaniak T, Stanek A, Basinski A, Kossakowska M, Gruca Z (2002) Factors determining morbidity and effectiveness in videothoracoscopic splanchnicectomy. Zentralbl Chir 127(11):950–955PubMedCrossRef

Ammori BJ (2003) Pancreatic surgery in the laparoscopic era. JOP 4:187–192PubMed

Howard TJ, Swofford JB, Wagner DL et al (2002) Quality of life after bilateral thoracoscopic splanchnicectomy: long-term evaluation in patients with chronic pancreatitis. J Gastrointest Surg 6:845–852PubMedCrossRef

10.

House JS, Landis KR, Umberson D (1988) Social relationships and health. Science 241:540–545PubMedCrossRef

11.

Ballantyne J (2003) Chronic pain following treatment for cancer: role of opioids. Oncologist 8:567–575PubMedCrossRef

12.

Breivik H (2001) Opioids in cancer and chronic non-cancer pain therapy—indications and controversies. Acta Anaesthsiol Scand 45:1059–1066CrossRef

13.

Ong KS, Keng SB (2003) The biological, social, and psychological relationship between depression and chronic pain. Cranio 21(4):286–294PubMed

14.

Stefaniak T, Vingerhoets A, Babinska D, Trus M, Glowacki J, Dymecki D, Makarewicz W, Kaska L, Kobiela J, Lachinski AJ, Stanek A, Gruca Z, Sledzinski Z, Markuszewska-Proczko M (2004) Psychological factors influencing results of cholecystectomy. Scand J Gastroenterol 39(2):127–132PubMedCrossRef

15.

Herbert RD (2005) Randomisation in clinical trials. Aust J Physiother 51(1):58–60PubMed

16.

Webster K, Cella D, Yost K (2003) The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation. Health Qual Life Outcomes 1:79PubMedCrossRef

17.

Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J (1993) The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 11:570–579PubMed

18.

Stefaniak T, Makarewicz W, Kossakowska M, Basiński A, Reszetow J, Kobiela J, Stanek A, Łachiński A, Konarski R, Gruca Z (2003) Application of the FACIT questionnaire in the evaluation of the quality of life in patients with chronic pancreatitis: Polish conditions. Pol Przegl Chir 75(10):956–965

19.

Yuan C, Foss JF, O’Connor M, Toledano A, Roizen M, Moss J (1996) Methylnaltrexone prevents morphine-induced delay in oral–cecal transit time without affecting analgesia: a double-blind randomized placebo-controlled trial. Clin Pharmacol Ther 59:469–475PubMedCrossRef

20.

Gan TJ, Ginsberg B, Glass PS, Fortney J, Jhaveri R, Perno R (1997) Opioidsparing effects of a low-dose infusion of naloxone in patient-administered morphine sulfate. Anesthesiology 87:1075–1081PubMedCrossRef

21.

Nicholson B (2003) Responsible prescribing of opioids for the management of chronic pain. Drugs 63(1):17–32PubMedCrossRef

22.

Jamison RN, Schein JR, Vallow S, Ascher S, Vorsanger GJ, Katz NP (2003) Neuropsychological effects of long-term opioid use in chronic pain patients. J Pain Symptom Manage 26(4):913–921PubMedCrossRef

23.

Martelli MF, Zasler ND, Bender MC, Nicholson K (2004) Psychological, neuropsychological, and medical considerations in assessment and management of pain. J Head Trauma Rehabil 19(1):10–28PubMedCrossRef

24.

Vallejo R, de Leon-Casasola O, Benyamin R (2004) Opioid therapy and immunosuppression: a review. Am J Ther 11(5):354–365PubMedCrossRef

25.

WHO (1990) Cancer pain relief and palliative care. World Health Organization, Technical Report Series No 804, Geneva, Switzerland

26.

Friedman JD, Dell Buono FA (2001) Opioid antagonists in the treatment of opioid-induced constipation and pruritus. Ann Pharmacother 35:85–91PubMedCrossRef

27.

Singh VV, Toskes PP (2003) Medical therapy for chronic pancreatitis pain. Curr Gastroenterol Rep 5:110–116PubMedCrossRef

28.

Raith K, Hochhaus G (2004) Drugs used in the treatment of opioid tolerance and physical dependence: a review. Int J Clin Pharmacol Ther 42:191–203PubMed

29.

Turk DC, Okifuji A (2002) Psychological factors in chronic pain: evolution and revolution. J Consult Clin Psychol 70(3):678–690PubMedCrossRef

30.

Hanck C, Whitcomb DC (2004) Alcoholic pancreatitis. Gastroenterol Clin North Am 33(4):751–765PubMedCrossRef

31.

Kreek MJ, Nielsen DA, LaForge KS (2004) Genes associated with addiction: alcoholism, opiate, and cocaine addiction. Neuromolecular Med 5:85–108PubMedCrossRef

32.

Finn AK, Whistler JL (2001) Endocytosis of the mu opioid receptor reduces tolerance and a cellular hallmark of opiate withdrawal. Neuron 32:829–839PubMedCrossRef

33.

South SM, Smith MT (2001) Analgesic tolerance to opioids. Pain Clin Updates 9:1–4

34.

Mao J, Price DD, Mayer DJ (1995) Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions. Pain 62:259–274PubMedCrossRef

Title: Opioid use determines success of videothoracoscopic splanchnicectomy in chronic pancreatic pain patients
Authors: Tomasz Stefaniak
Ad Vingerhoets
Wojciech Makarewicz
Lukasz Kaska
Jarek Kobiela
Barbara Kwiecińska
Aleksander Stanek
Andrzej J. Lachinski
Zbigniew Śledziński
Publication date: 01-03-2008
Publisher: Springer-Verlag
Published in: Langenbeck's Archives of Surgery / Issue 2/2008
Print ISSN: 1435-2443
Electronic ISSN: 1435-2451
DOI: https://doi.org/10.1007/s00423-007-0177-2

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Opioid use determines success of videothoracoscopic splanchnicectomy in chronic pancreatic pain patients

Abstract

Objective

Materials and methods

Results

Conclusion

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Objective

Materials and methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 2/2008

The risk to develop a recurrence of a gastric cancer—is it independent of time?

Liver transplantation as curative approach for advanced hepatocellular carcinoma: is it justified?

Reply to the commentary by M. Makuuchi

Role of the reverse-Trendelenberg patient position in maintaining low-CVP anaesthesia during liver resections

Limberg flap procedure for pilonidal sinus disease: results of 353 patients

Fatal hypoglycemia with levofloxacin use in an elderly patient in the post-operative period